Navigation Links
Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2010 Financial Results, Guidance for 2011
Date:2/10/2011

xilium faces may be found under the heading "Risk Factors" in Auxilium's Annual Report on Form 10-K for the year ended December 31, 2009 and in Auxilium's Quarterly Report on Form 10-Q for the period ended September 30, 2010 which are on file with the Securities and Exchange Commission. Given these risks and uncertainties, any or all of the forward-looking statements contained in this release may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Auxilium undertakes no obligation to update publicly any forward-looking statement.

AUXILIUM PHARMACEUTICALS, INC.Condensed Consolidated Statement of Operations(In thousands, except share and per share amounts)(Unaudited)Three Months Ended December 31,Twelve Months Ended December 31,2010200920102009Net revenues

$
,830$
48,027$   211,429$   164,039Operating expenses*:Cost of goods sold

17,16510,41649,72537,077Research and development

13,95411,37548,00551,398Selling, general and administrative

47,00838,711164,675129,181Total operating expenses

78,12760,502262,405217,656Loss from operations

(16,297)(12,475)(50,976)(53,617)Interest income (expense), net

(99)(38)(255)160Loss before income taxes

(16,396)(12,513)(51,231)(53,457)Provision for income taxes

-(614)--Net loss

$
(16,396)$
(11,899)$
(51,231)$
(53,457)Basic and diluted net loss percommon share

$
(0.34)$
(0.25)$
(1.08)$
(1.22)Weighted average common sharesoutstanding

47,666,40647,001,77947,426,84943,650,775*includes the following amountsof stock-based compensation expense:Cost of goods sold

$
46$
-$
55$
-Research and development

1,2831,0272,6985,048Selling, general and administrative

4,6203,33615,10912,852AUXILIUM PHARMACEUTICALS, INC.Selected Consolidated Balance Sheet Data(In thousands)(Unaudited)December 31,December 31,20102009Cash and cash equivalents'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Auxilium Pharmaceuticals to Announce Fourth Quarter and Full Year 2010 Results and Conduct Conference Call on Thursday, February 10, 2011
2. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
3. VioQuest Pharmaceuticals, Inc Q2/08 Review Issued by Scimitar Equity, LLC
4. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
5. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
6. Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
7. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
8. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
9. Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
10. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
11. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... (PRWEB) September 19, 2014 ... its potential to revolutionize the world has attracted ... corporations and small start-ups. The early years of ... projects largely due to the high risks involved, ... budgets earmarked for this evolving technology have been ...
(Date:9/19/2014)... , Sept. 19, 2014 Pfenex Inc. (NYSE ... development of high-value and difficult to manufacture proteins including ... at the 21 st Annual NewsMakers in the ... . Bertrand Liang , chief executive officer of ... programs and business strategy on Friday, September 26, 2014 ...
(Date:9/19/2014)... Dublin ... announced the addition of the  "Micro Market Monitor ... offering.       (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... fastest-growing segments in the chromatography market. The market ... expected to reach $2.0 billion by 2019, at ...
(Date:9/18/2014)... TX (PRWEB) September 18, 2014 ... integrated urological and interventional radiology products and services, ... known as cryotherapy and cryoablation) versus external beam ... Section of the American Urological Association (MAAUA) Annual ... , "Comparing Relative Effectiveness of Cryosurgery and External ...
Breaking Biology Technology:Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 2Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 3Growing R&D Investments & Developments in Nanomaterials to Drive the Global Nanotechnology Market, According to New Report by Global Industry Analysts, Inc. 4Pfenex to Present at Upcoming Industry Conference on September 26 2Micro Market Monitor : Global Pre-packed Chromatography Columns 2HealthTronics Announces Data Comparing Cryotherapy Versus Radiation for Treating Prostate Cancer Poster Presented at the American Urological Association Regional Meeting 2
... , , , ... (Nasdaq: GHDX ) today reported financial results and business progress for ... increased to $36.6 million in the second quarter of 2009 compared with $27.8 ... type DX(R) breast cancer test was $35.2 million in the second quarter ...
... 4 Oramed,Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com ... its wholly owned Israeli,subsidiary, Oramed Ltd., was awarded a ... 3.1 million ($828,000), from the Office of the Chief,Scientist ... of Israel. This,grant was awarded as government participation in ...
... , VENLO, The Netherlands, Aug. 4 QIAGEN N.V. (Nasdaq: ... call. The Webcast will take place at 9:30 a.m. EDT on Tuesday, August 11, ... Roland Sackers, Chief Financial Officer. , , ... When: 9:30 a.m. EDT on August 11, ...
Cached Biology Technology:Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 2Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 3Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 4Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 5Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 6Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 7Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 8Genomic Health Announces Second Quarter 2009 Financial Results and Business Progress 9Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist 2Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Second Quarter 2009 Financial Results Call Set for August 11 2
(Date:9/18/2014)... millions of Americans to undertake jaunts into the countryside each ... longer within a century, according to new research. , Climate ... the United States as summer temperatures linger later into the ... Ecology and Biogeography . For instance, the paper birch ... New Hampshire could change color one to three weeks ...
(Date:9/18/2014)... the first smartphone app that automatically reveals students, ... other words, your smartphone knows your state of ... how that affects you. , The StudentLife app, ... to their academic performance, also may be used ... monitor mental health, trigger intervention and improve productivity ...
(Date:9/18/2014)... be cheerful, happy-go-lucky characters, so you might expect that ... , In fact some dogs are distinctly more pessimistic ... , "This research is exciting because it measures ... non-invasively. It offers researchers and dog owners an insight ... said Dr Melissa Starling, from the Faculty of Veterinary ...
Breaking Biology News(10 mins):Fall foliage season may be later, but longer on warmer Earth 2Fall foliage season may be later, but longer on warmer Earth 3Fall foliage season may be later, but longer on warmer Earth 4New Dartmouth smartphone app reveals users' mental health, performance, behavior 2New Dartmouth smartphone app reveals users' mental health, performance, behavior 3New Dartmouth smartphone app reveals users' mental health, performance, behavior 4Dogs can be pessimists too 2Dogs can be pessimists too 3
... understudies. Now, an increasingly popular radioactive isotope has ... at the National Institute of Standards and Technology ... speed up clinical trials of many drugs and ... The number of medical images obtained through ...
... come in boy and girl varieties, but they do have ... Medical Center shows that some of the earliest evolved forms ... higher animals, including that distant cousin of fungus, the human. ... sex-determining genes from one of the oldest known types of ...
... ingestion of soil, or geophagy, has important health ... her colleagues from the Musum National dHistoire Naturelle ... dysfunctional behavior, geophagy has evolved as a practice ... particular study (1), to be published online this ...
Cached Biology News:Radioactive 'understudy' may aid medical imaging, drug development 2Evolution of the sexes: What a fungus can tell us 2Down to earth remedies for chimps 2
... microplate stacker system, offers fast and reliable ... devices:, , Ultra Evolution , SAFIRE monochromator ... SpectraFluor Plus , LS Series of Laser ... a wide range of detection and separation ...
... your life easier. It offers a wide array of ... balance. *Instruments supported: ... XS, XP, PR, SR, PG-S, PG, SG, AT, MT, ... User guidance on the balance ...
... The STag Purification Kits enable rapid ... STag fusion proteins produced from appropriate vectors. ... up to 1 mg target protein under ... incubated with S-protein Agarose, which specifically retains ...
Request Info...
Biology Products: